DengYueMed
Independent Intelligence on Global Oncology & Rare Disease Markets
Policy · Innovation · Market Access · Competitive Strategy
DengYueMed is an independent pharmaceutical intelligence platform delivering insights on drug innovation, pharmaceutical markets, and global regulatory policy. The platform covers oncology, rare diseases, regulatory developments, and pharmaceutical supply chains across major global markets including the United States, Europe, and China.
Lead Analysis
Latest Insights
Global Liver Cancer Drug Market Size and Outlook 2026: Innovation Driving a New Growth Cycle
April 11, 2026
Industry Intelligence
Drug Intelligence
Market Intelligence
Policy Intelligence
Rare Diseases
- 2026 Global Innovative Drug R&D and Regulatory Dynamics: ADC and Gene Therapies Lead a New Era
April 10, 2026 - Global Pharmaceutical Innovation and Regulatory Dynamics in 2026: Breakthroughs in Oncology and Rare Diseases
April 09, 2026 - Global Access to Thalassemia Gene Therapy in 2026: USA vs Europe vs China
April 08, 2026
Oncology
- 2026 Global Oncology Innovation: The Convergence of ADCs and Bispecific Antibodies
April 11, 2026 - Global Liver Cancer Drug Market Size and Outlook 2026: Innovation Driving a New Growth Cycle
April 11, 2026 - Gene Editing and Next-Generation Nucleic Acid Therapies: Toward Curative Medicine
April 10, 2026
Regulatory
- 2026 Global Innovative Drug R&D and Regulatory Dynamics: ADC and Gene Therapies Lead a New Era
April 10, 2026 - Global Pharmaceutical Innovation and Regulatory Dynamics in 2026: Breakthroughs in Oncology and Rare Diseases
April 09, 2026 - Why β₁-Selective Beta-Blockers Remain Important in Cardiovascular Therapy
March 30, 2026